These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12658725)

  • 1. Targeting peptides and positron emission tomography.
    Lundqvist H; Tolmachev V
    Biopolymers; 2002; 66(6):381-92. PubMed ID: 12658725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.
    Miller PW; Long NJ; Vilar R; Gee AD
    Angew Chem Int Ed Engl; 2008; 47(47):8998-9033. PubMed ID: 18988199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positron emission tomography: basic principle and radionuclides/probes for metabolic/functional analysis].
    Saga T; Yoshikawa K; Ishizu K
    Rinsho Byori; 2007 Jul; 55(7):630-8. PubMed ID: 17718059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.
    Schottelius M; Poethko T; Herz M; Reubi JC; Kessler H; Schwaiger M; Wester HJ
    Clin Cancer Res; 2004 Jun; 10(11):3593-606. PubMed ID: 15173065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of a cyclotron in the production of positron emitting radionuclides].
    Martí-Climent J; Peñuelas I; Calvo R; Giménez M; Gámez C; Richter J
    Rev Esp Med Nucl; 1999 Aug; 18(4):261-7. PubMed ID: 10481107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decay data and production yields of some non-standard positron emitters used in PET.
    Qaim SM
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):111-20. PubMed ID: 18174879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and application of [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO): a [18F]FDG-based prosthetic group for the chemoselective 18F-labeling of peptides and proteins.
    Wuest F; Berndt M; Bergmann R; van den Hoff J; Pietzsch J
    Bioconjug Chem; 2008 Jun; 19(6):1202-10. PubMed ID: 18481886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production.
    Uusijärvi H; Bernhardt P; Rösch F; Maecke HR; Forssell-Aronsson E
    J Nucl Med; 2006 May; 47(5):807-14. PubMed ID: 16644751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography: physics, instrumentation, and image analysis.
    Porenta G
    Wien Klin Wochenschr; 1994; 106(15):466-77. PubMed ID: 7941595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of positron emission tomography radiochemistry as relevant for food chemistry.
    Wuest F
    Amino Acids; 2005 Dec; 29(4):323-39. PubMed ID: 15997412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins.
    de Bruin B; Kuhnast B; Hinnen F; Yaouancq L; Amessou M; Johannes L; Samson A; Boisgard R; Tavitian B; Dollé F
    Bioconjug Chem; 2005; 16(2):406-20. PubMed ID: 15769096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative small animal PET imaging with nonconventional nuclides.
    Liu X; Laforest R
    Nucl Med Biol; 2009 Jul; 36(5):551-9. PubMed ID: 19520296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron follow-up in liquid water: II. Spatial and energetic study for the most important radioisotopes used in PET.
    Champion C; Le Loirec C
    Phys Med Biol; 2007 Nov; 52(22):6605-25. PubMed ID: 17975286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
    Hutchings M; Loft A; Hansen M; Pedersen LM; Berthelsen AK; Keiding S; D'Amore F; Boesen AM; Roemer L; Specht L
    Haematologica; 2006 Apr; 91(4):482-9. PubMed ID: 16585015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative imaging of iodine-124 with PET.
    Pentlow KS; Graham MC; Lambrecht RM; Daghighian F; Bacharach SL; Bendriem B; Finn RD; Jordan K; Kalaigian H; Karp JS; Robeson WR; Larson SM
    J Nucl Med; 1996 Sep; 37(9):1557-62. PubMed ID: 8790218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography.
    Hoffman EJ; Phelps ME
    Med Instrum; 1979; 13(3):147-51. PubMed ID: 440173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.
    Kaira K; Oriuchi N; Otani Y; Shimizu K; Tanaka S; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Dobashi K; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
    Clin Cancer Res; 2007 Nov; 13(21):6369-78. PubMed ID: 17975149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and future needs for standards of radionuclides used in positron emission tomography.
    Zimmerman BE
    Appl Radiat Isot; 2013 Jun; 76():31-7. PubMed ID: 23078834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.